# FDA Inspection 1111580 - Biomat USA, Inc. - October 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e7ff1d7d-f375-415c-9914-89276745d244
Source feed: FDA_Inspections

> FDA Inspection 1111580 for Biomat USA, Inc. on October 22, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1111580
- Company Name: Biomat USA, Inc.
- Inspection Date: 2019-10-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 998997 - 2016-11-16](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/aad3ee15-e503-4405-a5d3-90d771fc5579)
- [FDA Inspection 859546 - 2013-12-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/435c889e-2258-41d2-8992-dea6bd1a4293)
- [FDA Inspection 765732 - 2012-02-02](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d61131e9-5694-4b32-86b7-d39ce81ce95b)

Company: https://www.keypedia.com/companies/biomat-usa-inc/8faeff4c-5bb9-43ec-8d08-0c62515b3fea

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d